Status Epilepticus

Body Systems › Neurologic System › Status Epilepticus

Neurology Clinical reference

Status Epilepticus

Status epilepticus (SE) is seizure activity ≥5 minutes or ≥2 seizures without return to baseline. Time-critical — each minute without treatment increases mortality. Follow ACEP/AAN protocol.

status epilepticus SE refractory status epilepticus convulsive status epilepticus

Terms

ICD-10

Evidence

Trials

Latest evidence

Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.

• Epilepsy & behavior : E&B • 2020

2006

Community use of intranasal midazolam for managing prolonged seizures.

Kyrkou M, Harbord M, Kyrkou N • Journal of intellectual & developmental disability

2003

Treatment of out-of-hospital status epilepticus with diazepam rectal gel.

Fitzgerald BJ, Okos AJ, Miller JW • Seizure

Condition family & coding

Terms and documentation support

Condition matches & synonyms

Terms

Related diagnostic names, synonyms, and documentation wording that may appear in clinical references and charting.

Status epilepticus

ICD-10 quick links

Codes

For study support, terminology recognition, and documentation language.

G40.803 Other epilepsy, intractable, with status epilepticus G40.804 Other epilepsy, intractable, without status epilepticus G40.823 Epileptic spasms, intractable, with status epilepticus G40.824 Epileptic spasms, intractable, without status epilepticus G40.833 Dravet syndrome, intractable, with status epilepticus G40.834 Dravet syndrome, intractable, without status epilepticus G40.911 Epilepsy, unspecified, intractable, with status epilepticus G40.919 Epilepsy, unspecified, intractable, without status epilepticus

Common tests

Tests performed

Continuous EEG monitoring CT head MRI brain CBC BMP (Na/glucose/Ca/Mg) Tox screen AED levels LP (if meningitis concern) ABG

Common medications

Recognize the drug and the class

Stage 1 (0-5 min): Lorazepam 4mg IV (or Midazolam 10mg IM) Stage 2 (5-20 min): Levetiracetam 60 mg/kg IV or Valproate 40 mg/kg IV or Fosphenytoin Stage 3 (20-40 min): Intubation + Propofol or Midazolam infusion

Related nursing diagnoses

NANDA diagnoses & care plans

Use these direct links to open nursing diagnoses and care-plan support related to Status Epilepticus.

Risk for Injury Impaired Gas Exchange Risk for Aspiration Decreased Intracranial Adaptive Capacity

Recruiting clinical trials

Additional official research

RECRUITING N/A

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

NCT05756621

Status epilepticus (SE) is found in 20-30% of patients in coma after cardiac arrest, is often refractory to medical therapy and is considered a negative prognostic factor. Intensity and duration of treatment of refractory and super-refract…

RECRUITING N/A

Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE)

NCT05839418

SENSE-II/AROUSE is a prospective, multicenter registry for patients treated for SE. The primary objective is to document patients and SE characteristics, treatment modalities, EEG features, and outcome of consecutive adults admitted fir SE…

RECRUITING NA

KD Treatment for Super-refractory Status Epilepticus

NCT07496749

The purpose of the study is to investigate to evaluate the efficacy and safety of ketogenic diet (KD) as an adjunctive therapy in patients with Super Refractory Status Epilepticus (SRSE) in the intensive care unit (ICU).

RECRUITING NA

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

NCT06344338

The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus